Christoffer Laustsen1, Thomas Stockholm Nørlinger1, Haiyun Qi1, Per Mose Nielsen1, Jakob Appel Østergaard2,3, Allan Flyvbjerg2, Jan Henrik Ardenkjaer-Larsen4, Fredrik Palm5, and Hans Stødkilde Jørgensen1
1Department of Clinical Medicine, MR-Research Centre, Aarhus University, Aarhus, Denmark, 2Department of Endocrinology and Internal Medicine and Department of Clinical Medicine, Aarhus University, Aarhus, Denmark, 3The Danish Diabetes Academy, Odense, Denmark, 4Department of Electrical Engineering, Technical University of Denmark, Kgs Lyngby, Denmark, 5Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
Synopsis
Early diabetic
nephropathy (DN) disease progression is notoriously difficult to detect and
quantify before substantial histological damage has occurred. Recently,
hyperpolarized [1-13C]pyruvate has demonstrated increased lactate production,
implying increased lactate dehydrogenase activity, in the kidney early after
the onset of diabetes as a consequence of increased nicotinamide adenine
dinucleotide (NADH) substrate availability due to elevated flux through the
polyol pathway. Here we investigated whether this deranged
metabolic profile can be reversed by antioxidant treatment targeting the
pseudohypoxic condition.Purpose
To explore whether antioxidant treatment by TEMPOL reverses
pseudohypoxia-induced lactate production
1 in early DN in a rat model of insulinopenic
diabetes mellitus.
Methods
Twenty-four ten-week old
female Wistar rats were included in this study. The rats were randomly grouped
in a diabetic group of 10 untreated animals and a diabetic treated group of 8
animals receiving TEMPOL treatment in the drinking water for 3 weeks and a
healthy control group consisting of 6 animals that not receive TEMPOL. Diabetes
was induced by an intravenous injection of freshly prepared streptozotocin
(STZ; 55 mg/kg body weight; Sigma-Aldrich, St. Louis, USA) dissolved in 10
mmol/L cold citrate buffer (pH 4.5). Blood glucose was measured in
tail-capillary blood with a Contour blood glucose meter (Bayer Diabetes Care,
Copenhagen, Denmark). Rats were considered diabetic if the blood glucose levels
exceeded 15 mmol/L 48 h after administration of STZ. Up to three consecutive
examinations was performed 2, 3 and 4 weeks after the induction of diabetes. The
rats were anesthetized and hyperpolarized [1-13C]pyruvate polarized
in a SpinLab (GE Healthcare) was injected via a catheter in the tail vein.
Temperature, arterial oxygen saturation and respiration rate were monitored
throughout the experiment. Each examination consisted of one injection of 1.5
mL hyperpolarized [1-13C]pyruvate over 10 s. The experiments were
performed in a 3 T clinical MR system (GE Healthcare) equipped with a dual
tuned 13C/1H volume rat coil. A slice-selective 13C
IDEAL spiral sequence was used for hyperpolarized [1-13C]pyruvate
imaging acquiring images every 5 s initiated 20 s after the start of injection.
(Scanning) protocol was as follows: Flip angle=10º, 11 IDEAL echoes and one
initial spectrum per IDEAL encoding, TR/TE/ΔTE=100 ms/0.9 ms/0.9 ms, FOV=80x80
mm2, 5 x 5 mm real resolution and an axial slice thickness of 15 mm covering
both kidneys.
Results
All rats
receiving STZ developed sustained hyperglycaemia within 48 h. No significant
changes were observed in body weight gain over the period and no differences
were found in body temperature, arterial oxygen saturation and respiration rate
between among the three groups. As
previously reported, untreated diabetic rats had increased renal lactate
production. However, chronic antioxidant treatment with TEMPOL significantly
attenuated the diabetes-induced lactate production (p=0.03 versus untreated
diabetics) although still being elevated compared to normoglycemic controls
(p=0.04, Figure 1A). No significance effects of diabetes or TEMPOL treatment
were observed on alanine or bicarbonate productions (Figure 1B-C).
Discussion
This
study demonstrates that
the diabetes-induced elevation of the lactate-to-pyruvate ratio can be
attenuated by antioxidant treatment, which demonstrates a pivotal role of
oxidative stress for the renal metabolic alterations occurring in early
diabetes.
Conclusion
The clinical impact of
reversal of the pseudo-hypoxic condition, is currently unknown, thus further
studies are needed to elucidate the importance of reversing the pseudo-hypoxic
condition.
Acknowledgements
The study was supported
by The Danish Research Council, The Danish Kidney Foundation, Helen and Ejnar
Bjørnows Foundation and the strategic research council. Henrik Vestergaard
Nielsen is acknowledged for his expert laboratory assistance. JAØ was supported
by a fellowship from the Danish Diabetes Academy supported by the Novo Nordisk
Foundation.References
1 Laustsen C, et al. Diabetes Metab Res Rev. 2013,
29:125-129.